Growth Metrics

RemSleep Holdings (RMSL) Income from Continuing Operations (2010 - 2025)

RemSleep Holdings recorded quarterly Income from Continuing Operations of 334894.0 in Q4 2025, up 85.52% quarter-over-quarter from 2312146.0 in Q3 2025, and down 4.03% year-over-year from 348970.6 in Q4 2024.

RemSleep Holdings' Income from Continuing Operations history runs 16 years deep, the most recent figure standing at 334894.0 for Q4 2025.

  • In Q4 2025, Income from Continuing Operations fell 4.03% year-over-year to 334894.0; the TTM figure through Dec 2025 stood at 3020300.0 (down 180.18% YoY), while the FY2025 annual figure was 3640300.0, down 179.16% from the prior year.
  • Income from Continuing Operations came in at 334894.0 for Q4 2025 at RemSleep Holdings, up from 2312146.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 85488.0 in Q1 2025 to a low of 2363695.0 in Q2 2021.
  • A 5-year average of 559419.1 and a median of 314229.5 in 2022 frame the typical range for Income from Continuing Operations.
  • Across the five-year window, Income from Continuing Operations slumped 6186.82% in 2021 and soared 81.37% in 2022, its largest moves.
  • RemSleep Holdings' Income from Continuing Operations stood at 158353.0 in 2021, then sank by 163.86% to 417823.0 in 2022, then sank by 153.2% to 1057948.0 in 2023, then surged by 69.57% to 321909.0 in 2024, then fell by 4.03% to 334894.0 in 2025.
  • According to Business Quant data, Income from Continuing Operations over the past three periods registered 334894.0, 2312146.0, and 287772.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 1.08 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 745.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 1.15 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 380.70 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 273.95 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 199.50 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 411.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 220.30 Mn
10 RemSleep Holdings - - -7,636.00 -334,894.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -334,894.00
Sep 30, 2025 -2.31 Mn
Jun 30, 2025 -287,772.00
Mar 31, 2025 -85,488.00
Dec 31, 2024 -321,909.00
Sep 30, 2024 -277,909.00
Jun 30, 2024 -225,599.00
Mar 31, 2024 -252,580.00
Dec 31, 2023 -1.06 Mn
Sep 30, 2023 -270,433.00
Jun 30, 2023 -223,198.00
Mar 31, 2023 -226,259.00
Dec 31, 2022 -417,823.00
Sep 30, 2022 -312,160.00
Jun 30, 2022 -440,292.00
Mar 31, 2022 -316,299.00
Dec 31, 2021 -158,353.00
Sep 30, 2021 -832,159.00
Jun 30, 2021 -2.36 Mn
Mar 31, 2021 -471,466.00
Dec 31, 2020 -669,289.00
Sep 30, 2020 -271,474.00
Jun 30, 2020 38,833.00
Mar 31, 2020 -273,522.00
Dec 31, 2019 -872,832.00
Sep 30, 2019 -77,148.00
Jun 30, 2019 -2.35 Mn
Mar 31, 2019 -591,732.00
Dec 31, 2018 405,951.00
Sep 30, 2018 -348,919.00
Jun 30, 2018 -307,613.00
Mar 31, 2018 -162,121.00
Dec 31, 2017 -222,718.00
Sep 30, 2017 -110,048.00
Jun 30, 2017 -285,596.00
Mar 31, 2017 -172,603.00
Dec 31, 2016 -169,805.00
Sep 30, 2016 -241.00
Jun 30, 2016 -3,230.00
Mar 31, 2016 -26,260.00
Dec 31, 2015 -13,367.00
Sep 30, 2015 -230.00
Jun 30, 2015 -38,613.00
Mar 31, 2015 -34,163.00
Dec 31, 2014 -212,405.00
Sep 30, 2014 21,957.00
Jun 30, 2014 21,415.00
Mar 31, 2014 21,415.00
Dec 31, 2013 -215,045.00
Sep 30, 2013 -180,858.00
Jun 30, 2013 -792,470.00
Mar 31, 2013 -206,286.00
Dec 31, 2012 -261,746.00
Sep 30, 2012 -470,642.00
Jun 30, 2012 -654,141.00
Mar 31, 2012 -17,254.00
Dec 31, 2011 -22,661.00
Jun 30, 2011 -69,188.00
Mar 31, 2011 -19,061.00
Dec 31, 2010 -112.88 Mn
Sep 30, 2010 -331,561.00